Impact of '4+7' volume-based drug procurement on the use of policy-related original and generic drugs: a natural experimental study in China.

BMJ Open · 2022 · PMC8921850 · PMID 35288385

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

After the ‘4+7’ policy, the growth rate of ‘4+7’ List generic drugs showed a trend of tertiary hospitals (84.95%)>secondary hospitals (42.62%)>PHCs (29.17%); consistently, the increased value in the use proportion of generic drugs presented the same trend of tertiary hospitals (25.27%)>secondary hospitals (15.08%)>PHCs (12.00%).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.